Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer

A need exists for seeking effective treatments for castration-resistant prostate cancer (CRPC) in response to its emergence following androgen deprivation therapy as a major clinical problem. In the present study, we investigated the chemopreventive and chemotherapeutic potential of luteolin, a flav...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Carcinogenesis
Päätekijät: Naiki-Ito, Aya, Naiki, Taku, Kato, Hiroyuki, Iida, Keitaro, Etani, Toshiki, Nagayasu, Yuko, Suzuki, Shugo, Yamashita, Yoriko, Inaguma, Shingo, Onishi, Masaya, Tanaka, Yasuhito, Yasui, Takahiro, Takahashi, Satoru
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Carcinogenesis
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7422625/
https://ncbi.nlm.nih.gov/pubmed/31805186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgz193
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia